PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results : Arrhythmias (Amiodarone hydrochloride - Arrhythmias)
Records returned : 22 (on 07 Nov 2024 at 09:57:48). Return to search results for ' Arrhythmias '.
Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
02.03.02
Amber
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
02.04.00
Green
Formulations :
- Oral solution
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
02.04.00
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
02.01.01
Green
Formulations :
- Elixir
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
ONE 62.5mcg tablet is equivalent to 50mcg (1ml) of elixir
02.04.00
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
02.04.00
04.07.04
Green
Formulations :
- Modified release capsules
- Oral solution
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
02.04.00
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
02.06.02
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
02.03.02
Blue
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Specialist initiation and at least one month supply before transfer to primary care
02.03.02
Blue
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Specialist initiation and at least one month supply before transfer to primary care
Blue
Formulations :
- Modified release tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Specialist initiation and at least one month supply before transfer to primary care
02.03.02
Blue
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Specialist initiation and at least one month supply before transfer to primary care
Red
Formulations :
- Injection
- Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
Important
Restricted to cardiology / Theatres / ITU / Resus
02.04.00
Red
Formulations :
- Intravenous injection (IV)
- Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
02.03.02
Red
Formulations :
- Injection
ASPH
RSFT
SASH
SABP
Primary Care
Important
Unlicensed.
For use or advice by cardiology consultants only.
02.03.02
04.07.03
Red
Formulations :
- Infusion
- Injection
ASPH
RSFT
SASH
SABP
Primary Care
02.04.00
Red
Formulations :
- Injection
ASPH
RSFT
SASH
SABP
Primary Care
02.03.02
Red
Formulations :
- Injection
ASPH
RSFT
SASH
SABP
Primary Care
Important
Unlicensed
02.06.02
Red
Formulations :
- Injection
ASPH
RSFT
SASH
SABP
Primary Care
02.03.02
10.02.02
Red
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Namuscla brand is non-preferred for this indication
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients